Literature DB >> 19538118

Chitosan-based systems for the delivery of vaccine antigens.

H Ciğdem Arca1, Merve Günbeyaz, Sevda Senel.   

Abstract

This review discusses the current status of chitosan and its derivatives as adjuvants and delivery systems in vaccine delivery, and their future possibilities and challenges. After a brief introduction to adjuvants and delivery systems, chitosan will be described in detail in regard to vaccine formulation. Applications of chitosan and its derivatives will be reviewed and their proposed mechanisms in the enhancement of immune responses will be discussed.

Mesh：

Substances：

Year:  2009        PMID： 19538118     DOI： 10.1586/erv.09.47

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


  37 in total

1.  Development and Evaluation of CmeC Subunit Vaccine against Campylobacter jejuni.

Authors:  Ximin Zeng; Fuzhou Xu; Jun Lin
Journal:  J Vaccines Vaccin       Date:  2010-01-01

Review 2.  Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.

Authors:  Alan Smith; Michael Perelman; Michael Hinchcliffe
Journal:  Hum Vaccin Immunother       Date:  2013-12-17       Impact factor: 3.452

3.  Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.

Authors:  Andreja Erman; Veronika Križan Hergouth; Matthew G Blango; Mojca Kerec Kos; Matthew A Mulvey; Peter Veranic
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

4.  Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection.

Authors:  Lori W Norton; Jaehyung Park; Julia E Babensee
Journal:  J Control Release       Date:  2010-06-02       Impact factor: 9.776

5.  The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells.

Authors:  Bhanuprasanth Koppolu; David A Zaharoff
Journal:  Biomaterials       Date:  2012-12-27       Impact factor: 12.479

6.  Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma.

Authors:  Angie S Morris; Sara C Sebag; John D Paschke; Amaraporn Wongrakpanich; Kareem Ebeid; Mark E Anderson; Isabella M Grumbach; Aliasger K Salem
Journal:  Mol Pharm       Date:  2017-05-09       Impact factor: 4.939

7.  Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice.

Authors:  Mushtaq Ahmed; Hongmei Jiao; Racquel Domingo-Gonzalez; Shibali Das; Kristin L Griffiths; Javier Rangel-Moreno; Uma M Nagarajan; Shabaana A Khader
Journal:  J Leukoc Biol       Date:  2017-03-03       Impact factor: 4.962

Review 8.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

9.  Chitosan enhances nanoparticle delivery from the reproductive tract to target draining lymphoid organs.

Authors:  Jaehyung Park; Renuka Ramanathan; Linhchi Pham; Kim A Woodrow
Journal:  Nanomedicine       Date:  2017-04-20       Impact factor: 5.307

Review 10.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.